These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 108709)

  • 1. MAO inhibition and the effects of centrally administered LSD, serotonin, and 5-methoxytryptamine on the conditioned avoidance response in rats.
    Prozialeck WC; Vogel WH
    Psychopharmacology (Berl); 1979 Feb; 60(3):309-10. PubMed ID: 108709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation by deprenyl of the autoreceptor-mediated inhibition of [3H]-5-hydroxytryptamine release by 5-methoxytryptamine.
    Galzin AM; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):330-3. PubMed ID: 3093900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective monoamine oxidase (MAO) inhibitors on conditioned avoidance responses (CAR) of rats.
    Timár J; Knoll B; Gyarmati Z; Knoll J
    Pol J Pharmacol Pharm; 1979; 31(4):251-60. PubMed ID: 523335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies.
    Whitaker-Azmitia PM; Zhang X; Clarke C
    Neuropsychopharmacology; 1994 Oct; 11(2):125-32. PubMed ID: 7840864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R; Botting R; Coulson P; Spanswick G
    Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
    Blier P; De Montigny C; Azzaro AJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
    Celada P; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of monoamine oxidase in monkey heart.
    Katayama M; Kobayashi S; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
    Miklya I
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):15-22. PubMed ID: 18771016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
    Boullin DJ; Green AR
    Adv Biochem Psychopharmacol; 1976; 15():127-40. PubMed ID: 15408
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I; Ross SB
    Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.